Company Active LTD

Company profile

Nemaura Pharma Limited

Nemaura Pharma Nemaura Pharma

Nemaura Pharma Limited is a UK company with status active founded in 2005 based in North West England.

CRN
05636878
Founded
2005
Age
20

Overview

Legal name
NEMAURA PHARMA LIMITED
Region
North West England
Registered address
1ST FLOOR, FAIRCLOUGH HOUSE
CHURCH STREET
CHORLEY
ENGLAND
PR7 4EX
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Nemaura Pharma Limited
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

5 events
29 Oct
2025

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2024

Accounts due

Accounts Due

Next accounts due date

15 Oct
2024

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2023

Accounts filed

Accounts

Last accounts made up date

25 Nov
2005

Incorporated

Inception

Company registered at Companies House

Public funding

6 awards
First funded
2008
Funded years
2008, 2011, 2013, 2014, 2022, 2024
Age at first award
2 years

Projects

2024 Collaborative R&D

Development of a novel microneedle based technology with integrated delivery confirmation to enhance self-administration reliability of needle-free vaccines.

1 Aug 2024 to 30 Apr 2025

Awarded
£45,367
Total cost £64,810

The healthcare and vaccine delivery sectors, while essential, face significant challenges in ensuring global vaccine accessibility and minimising wastage. These challenges are compounded by the reliance on cold chain logistics and the necessity for skilled healthcare personnel for vaccine administration. In response, CipherX and Nemaura have embarked on a...

2022 EU-Funded Lead participant

Lamma

1 Nov 2022 to 31 Oct 2024

Awarded
£231,580
Total cost £385,955
2014 GRD Proof of Concept Lead participant

Micro Needle

1 Jan 2014 to 31 Mar 2015

Awarded
£100,000
Total cost £177,939

Nemaura Pharma has developed a number of drug delivery systems focusing on delivery of drugs through the skin. We wish to undertake a proof of concept to deliver the Tdap vaccine (Tetanus, Diphtheria and Pertussis) using a solid micro-dose injector. The Tdap booster vaccine must be adminsitered several times over a persons life span, and also to pregnant ...

2013 GRD Proof of Market Lead participant

Acne Prevention

1 Dec 2013 to 31 Mar 2015

Awarded
£24,999
Total cost £42,537

Our proposal is to investigate the feasibility of applying reverse iontophoresis to treat acne by removing matter which clogs pores in the skin, leading to acne and pimples. Before we invest in the risky R & D exercise to modify and apply our process in this way to create a new product ‘Acne prevention and Treatment Device (APTD), we need to understand th...

2011 GRD Development of Prototype Lead participant

Nemaura Continuous Glucose Monitoring (CGM) Patch

1 Nov 2011 to 31 Mar 2013

Awarded
£250,000
Total cost £640,077

The CGM Patch is a non-invasive continuous glucose monitoring patch that is worn around the arm or thigh to continuously monitor the blood glucose levels in a patient without the use of needles, without the need for blood letting and the associated difficulties and potential for infection, in a very simple user friendly format. The CGM patch consists of a...

2008 Collaborative R&D Lead participant

Microsystems based self-regulating diagnostics

1 Sep 2008 to 28 Feb 2011

Awarded
£181,762
Total cost £546,383

Awaiting Public Summary

Product types

Collaborative R&D EU-Funded GRD Development of Prototype GRD Proof of Concept GRD Proof of Market